新华制药：缬沙坦胶囊取得《药品注册证书》

Group 1 - Core viewpoint: XinHua Pharmaceutical has received the drug registration certificate for Valsartan capsules from the National Medical Products Administration [1] - Company market capitalization: As of the report, XinHua Pharmaceutical's market value is 10.8 billion yuan [2]